Spontaneous Gastric Intramural Hematoma: Case Report and Literature Review
January 12, 2022 updated by: Omar Tabbikha, University of Balamand
Patient previously healthy found to have spontaneous gastric intramural hematoma
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
28 year old male patient previously healthy presented with diarrhea and diffuse abdominal pain of 1 week duration that exacerbated 1 day prior to presentation.
CT showed anterior abdominal mass possibly from the outer gastric wall.
Gastroscopy suspected a submucosal tumor in the body and antrum.
Patient's pain exacerbated and developed drop in hemoglobin.
Urgent CT scan showed a bleeding gastric tumor.
Urgent laparotomy identified a bleeding gastric lesion at greater curvature.
Partial gastrectomy done with abutting mesocolon resection.
Surgical specimen pathology showed gastric intramural hematoma that was considered spontaneous.
Study Type
Observational
Enrollment (Actual)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beirut, Lebanon
- University Of balamand
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients previously healthy presenting with bleeding gastric mass
Description
Inclusion Criteria:
- any patient presenting with gastric bleeding tumors
Exclusion Criteria:
- patients on anticoagulants and patient with gastric medical history
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spontaneous gastric intramural hematoma
Time Frame: 1 month
|
Spontaneous gastric intramural hematoma
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Omar Tabbikha, MD, University Of balamand
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2021
Primary Completion (Actual)
December 15, 2021
Study Completion (Actual)
January 1, 2022
Study Registration Dates
First Submitted
January 12, 2022
First Submitted That Met QC Criteria
January 12, 2022
First Posted (Actual)
January 24, 2022
Study Record Updates
Last Update Posted (Actual)
January 24, 2022
Last Update Submitted That Met QC Criteria
January 12, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UBalamand
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Publishing a case report of our finding
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.